232 related articles for article (PubMed ID: 21846121)
1. Cocrystals of quercetin with improved solubility and oral bioavailability.
Smith AJ; Kavuru P; Wojtas L; Zaworotko MJ; Shytle RD
Mol Pharm; 2011 Oct; 8(5):1867-76. PubMed ID: 21846121
[TBL] [Abstract][Full Text] [Related]
2. A phospholipid complex to improve the oral bioavailability of flavonoids.
Wang H; Cui Y; Fu Q; Deng B; Li G; Yang J; Wu T; Xie Y
Drug Dev Ind Pharm; 2015; 41(10):1693-703. PubMed ID: 25496311
[TBL] [Abstract][Full Text] [Related]
3. Preparation of quercetin-nicotinamide cocrystals and their evaluation under
Wu N; Zhang Y; Ren J; Zeng A; Liu J
RSC Adv; 2020 Jun; 10(37):21852-21859. PubMed ID: 35516602
[TBL] [Abstract][Full Text] [Related]
4. Cocrystal of Apixaban-Quercetin: Improving Solubility and Bioavailability of Drug Combination of Two Poorly Soluble Drugs.
Zhang L; Kong D; Wang H; Jiao L; Zhao X; Song J; Yang D; Yang H; Yang S; Du G; Lu Y
Molecules; 2021 May; 26(9):. PubMed ID: 34063645
[TBL] [Abstract][Full Text] [Related]
5. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability.
Tran TH; Guo Y; Song D; Bruno RS; Lu X
J Pharm Sci; 2014 Mar; 103(3):840-52. PubMed ID: 24464737
[TBL] [Abstract][Full Text] [Related]
6. Chrysin cocrystals: Characterization and evaluation.
Chadha R; Bhalla Y; Nandan A; Chadha K; Karan M
J Pharm Biomed Anal; 2017 Feb; 134():361-371. PubMed ID: 27894779
[TBL] [Abstract][Full Text] [Related]
7. Naringenin Cocrystals Prepared by Solution Crystallization Method for Improving Bioavailability and Anti-hyperlipidemia Effects.
Cui W; He Z; Zhang Y; Fan Q; Feng N
AAPS PharmSciTech; 2019 Feb; 20(3):115. PubMed ID: 30771018
[TBL] [Abstract][Full Text] [Related]
8. Tuning the Pharmacokinetic Performance of Quercetin by Cocrystallization.
Haskins MM; Kavanagh ON; Sanii R; Khorasani S; Chen JM; Zhang ZY; Dai XL; Ren BY; Lu TB; Zaworotko MJ
Cryst Growth Des; 2023 Aug; 23(8):6059-6066. PubMed ID: 37547881
[TBL] [Abstract][Full Text] [Related]
9. Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: Screening, crystal structures, thermochemical and solubility studies.
Drozd KV; Manin AN; Churakov AV; Perlovich GL
Eur J Pharm Sci; 2017 Mar; 99():228-239. PubMed ID: 28011126
[TBL] [Abstract][Full Text] [Related]
10. Baicalein-nicotinamide cocrystal with enhanced solubility, dissolution, and oral bioavailability.
Huang Y; Zhang B; Gao Y; Zhang J; Shi L
J Pharm Sci; 2014 Aug; 103(8):2330-7. PubMed ID: 24903146
[TBL] [Abstract][Full Text] [Related]
11. Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide.
Li J; Wang L; Ye YQ; Fu X; Ren Q; Zhang H; Deng Z
Eur J Pharm Sci; 2016 Mar; 85():47-52. PubMed ID: 26836368
[TBL] [Abstract][Full Text] [Related]
12. Novel furosemide cocrystals and selection of high solubility drug forms.
Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
[TBL] [Abstract][Full Text] [Related]
13. Cocrystals of diacerein: Towards the development of improved biopharmaceutical parameters.
Tomar S; Chakraborti S; Jindal A; Grewal MK; Chadha R
Int J Pharm; 2020 Jan; 574():118942. PubMed ID: 31830577
[TBL] [Abstract][Full Text] [Related]
14. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
Hong C; Xie Y; Yao Y; Li G; Yuan X; Shen H
Pharm Res; 2015 Jan; 32(1):47-60. PubMed ID: 24939640
[TBL] [Abstract][Full Text] [Related]
15. Dry Mechanochemical Synthesis of Caffeine/Oxalic Acid Cocrystals and Their Evaluation by Powder X-Ray Diffraction and Chemometrics.
Otsuka Y; Ito A; Takeuchi M; Tanaka H
J Pharm Sci; 2017 Dec; 106(12):3458-3464. PubMed ID: 28797789
[TBL] [Abstract][Full Text] [Related]
16. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles.
Wu TH; Yen FL; Lin LT; Tsai TR; Lin CC; Cham TM
Int J Pharm; 2008 Jan; 346(1-2):160-8. PubMed ID: 17689897
[TBL] [Abstract][Full Text] [Related]
17. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-telmisartan polymeric cocrystals for improving oral absorption: In vitro and in vivo evaluation.
Ganesh M; Ubaidulla U; Rathnam G; Jang HT
Int J Biol Macromol; 2019 Jun; 131():879-885. PubMed ID: 30905757
[TBL] [Abstract][Full Text] [Related]
19. Rucaparib cocrystal: Improved solubility and bioavailability over camsylate.
Xia M; Jiang Y; Cheng Y; Dai W; Rong X; Zhu B; Mei X
Int J Pharm; 2023 Jan; 631():122461. PubMed ID: 36462737
[TBL] [Abstract][Full Text] [Related]
20. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
